Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Regular dose of aspirin can lower risk of inherited bowel cancer: Study
The research carried out by Universities of Newcastle and Leeds, and funded by Cancer Research UK, NIHR, Bayer Pharma AG and the…
Phenomenex introduces bioZEN, a 2.6 µm WidePore C4 core-shell LC
The new addition to its existing portfolio of bioZen biological workflow products can help in the improved analysis of large…
Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management
Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of…
BDR Pharma urges regulators to expedite manufacturing, marketing license process for remdesivir
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in…
Cancer CART therapy: What are the benefits and stakes?
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how…
Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir
Dr Reddy’s will receive technology transfer from Gilead for manufacturing of this drug and needs to do the manufacturing scale-up…
Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK + BLU-U Data for skin cancer…
Analyses of long-term data confirm that the continued and clinically meaningful results of ODOMZO (sonidegib) in people with…
Pharma MSMEs ask government to extend incentives of PLI scheme
Due to incremental sales and production provisions of the PLI scheme, the MSME sector is not able to avail the desired benefits
Lupin ties up with Omron Healthcare
To strengthen respiratory disease management facilities
Medical device maker Omron Healthcare India has joined hands with…
Naari completes acquisition of ANDAs from Intas Pharmaceuticals
The portfolio acquired comprises eight US FDA approved ANDAs and two products pending approval
Naari Pharma has entered…